Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering

Bio-Medical Materials and Engineering

Volumn 25, Issue , 2015, Pages S137-S143

  Zhang, Lei ^a   Zhao, Yong Hen ^a   Guan, Zheng ^a   Ye, Jun Song ^a,b   De Isla, Natalia ^b   Stoltz, Jean François ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b CNRS   (France)

Author keywords

differentiation; hepatocyte; liver tissue engineering; Wharton's jelly mesenchymal stem cells (WJ MSCs)

Indexed keywords

ARTIFICIAL ORGANS; BIOACTIVITY; CELL CULTURE; CELL ENGINEERING; CELLS; CYTOLOGY; DIFFERENTIATION (CALCULUS); SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE;

3-DIMENSIONAL MATRIX; BIOARTIFICIAL LIVER; CHRONIC LIVER DISEASE; DECELLULARIZED; HEPATOCYTES; LIVER TISSUE ENGINEERING; LIVER TRANSPLANTATION; MESENCHYMAL STEM CELL;

TISSUE ENGINEERING;

CYTOKINE; GROWTH FACTOR;

ACUTE ON CHRONIC LIVER FAILURE; AUTOGRAFT; BIOARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL RENEWAL; CELLS BY BODY ANATOMY; COCULTURE; CONFERENCE PAPER; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOPHENOTYPING; LIVER; LIVER CELL; LIVER DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; STEM CELL EXPANSION; TISSUE ENGINEERING; TISSUE SCAFFOLD; WHARTON JELLY; ARTIFICIAL LIVER; BIOREACTOR; CELL CULTURE; CYTOLOGY; DEVICES; MESENCHYMAL STROMA CELL; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PROSTHESIS;

BIOREACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; LIVER, ARTIFICIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; ORGAN CULTURE TECHNIQUES; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WHARTON JELLY;

EID: 84919931864     PISSN: 09592989     EISSN: 18783619     Source Type: Journal    
DOI: 10.3233/BME-141232     Document Type: Conference Paper

References (29)

1. Q. Jiang, S. Takahagi and J. Uitto, Administration of bone marrow derived mesenchymal stem cells into the liver: potential to rescue pseudoxanthoma elasticum in a mouse model (Abcc6), J. Biomed. Biotechnol. 2012 (2012), Article ID 818937.
2. P.L. Kang et al., Nano-sized collagen I molecules enhanced the differentiation of rat mesenchymal stem cells into cardiomyocytes, J. Biomed. Mater. Res. A 101(10) (2013), 2808-2816.
3. H.S. Wang et al., Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord, Stem Cells 22(7) (2004), 1330-1337.
4. D.L. Troyer and M.L.Weiss, Wharton's jelly-derived cells are a primitive stromal cell population, Stem Cells 26(3) (2008), 591-599.
5. R.R. Bhonde et al., Making surrogate beta-cells from mesenchymal stromal cells: perspectives and future endeavors, Int. J. Biochem. Cell Biol. 46 (2014), 90-102.
6. N.K. Mekala, R.R. Baadhe and S.R. Parcha, Study on osteoblast like behavior of umbilical cord blood cells on various combinations of PLGA scaffolds prepared by salt fusion, Curr. Stem Cell Res. Ther. 8(3) (2013), 253-259.
7. S. Liu et al., Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells, Cell. Immunol. 278(1,2) (2012), 35-44.
8. S.Y. An et al., Valproic acid promotes differentiation of hepatocyte-like cells from whole human umbilical cord-derived mesenchymal stem cells, Tissue Cell 46(2) (2014), 127-135.
9. S. Zhang et al., Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation, Tissue Eng. Part A 18(13,14) (2012), 1352-1364.
10. A. Otte et al., Mesenchymal stem cells maintain long-term in vitro stemness during explant culture, Tissue Eng. Part C Methods 19(12) (2013), 937-948.
11. N. Daviaud et al., Organotypic cultures as tools for optimizing central nervous system cell therapies, Exp. Neurol. 248 (2013), 429-440.
12. R. Carlin et al., Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells, Reprod. Biol. Endocrinol. 4 (2006), 8.
13. C.Y. Fong et al., Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment, Stem Cell. Rev. 8(1) (2012), 195-209.
14. H.L. Jin et al., Dynamic expression of specific miRNAs during erythroid differentiation of human embryonic stem cells, Mol. Cells 34(2) (2012), 177-183.
15. S. Balasubramanian et al., Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells, Cytotherapy 14(1) (2012), 26-33.
16. M.S. Rao and M.P. Mattson, Stem cells and aging: expanding the possibilities, Mech. Ageing Dev. 122(7) (2001), 713-734.
17. M.F. Pittenger et al.,Multilineage potential of adult human mesenchymal stem cells, Science 284(5411) (1999), 143-147.
18. C. Zhou et al., Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes, Cell Immunol. 272(1) (2011), 33-38.
19. R. Anzalone et al., New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity, Stem Cells Dev. 19(4) (2010), 423-438.
20. M. Knippenberg et al., Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation, Tissue Eng. 11(11,12) (2005), 1780-1788.
21. D.A. De Ugarte et al., Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow, Immunol. Lett. 89(2,3) (2003), 267-270.
22. D. Campard et al., Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells, Gastroenterology 134(3) (2008), 833-848.
23. Q. Zhao et al., Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells, Cytotherapy 11(4) (2009), 414-426.
24. Y.N. Zhang, P.C. Lie and X. Wei, Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells, Cytotherapy 11(5) (2009), 548-558.
25. Z. Zhang et al., Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients, J. Gastroenterol. Hepatol. 27(Suppl. 2) (2012), 112-120.
26. M. Shi et al., Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients, Stem Cells Transl. Med. 1(10) (2012), 725-731.
27. Y. Yan et al., Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo, Liver Int. 29(3) (2009), 356-365.
28. T. Li et al., Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis, Stem Cells Dev. 22(6) (2013), 845-854.
29. L.L. Shi, F.P. Liu and D.W. Wang, Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis, Am. J. Med. Sci. 342(3) (2011), 212-217.